Search AMIA.org

We discuss challenges using computational modeling approaches for personalized prediction in clinical practice to predict treatment response for rare diseases treated by novel therapies using clinical oncology as an example context. Several challenges are discussed, including data scarcity, data sparsity, and difficulties in establishing interdisciplinary teams. Machine learning (ML), mechanistic modeling (MM), and hybrid modeling (HM) are discussed in the context of these challenges.

Electronic Health Records (EHRs) sampled from different populations can introduce unwanted biases, limit individual-level data sharing, and make the data and fitted model hardly transferable across different population groups. In this context, our main goal is to design an effective method to transfer knowledge between population groups, with computable guarantees for suitability, and that can be applied to quantify treatment disparities.

Accurately measuring patient similarity is essential for precision medicine, enabling personalized predictive modeling, disease subtyping, and individualized treatment by identifying patients with similar characteristics to an index patient. This study aims to develop an electronic health record-based patient similarity estimation framework to enhance personalized predictive modeling for Acute Kidney Injury (AKI), a complex and life-threatening condition where accurate prediction is critical for timely intervention.

To improve prediction of chronic kidney disease (CKD) progression to end-stage renal disease (ESRD) using machine learning (ML) and deep learning (DL) models applied to integrated clinical and claims data with varying observation windows, supported by explainable artificial intelligence (AI) to enhance interpretability and reduce bias.

Clinicians currently make decisions about placing an intracranial pressure (ICP) monitor in children with traumatic brain injury (TBI) without the benefit of an accurate clinical decision support tool. The goal of this study was to develop and validate a model that predicts placement of an ICP monitor and updates as new information becomes available.

The objective of this study is to provide an overview of the current landscape of individualized treatment effects (ITE) estimation, specifically focusing on methodologies proposed for time-series electronic health records (EHRs). We aim to identify gaps in the literature, discuss challenges, and propose future research directions to advance the field of personalized medicine.

This study addresses the significant challenges posed by emerging SARS-CoV-2 variants, particularly in developing diagnostics and therapeutics. Drug repurposing is investigated by identifying critical regulatory proteins impacted by the virus, providing rapid and effective therapeutic solutions for better disease management.

Report the development of the patient-centered myAURA application and suite of methods designed to aid epilepsy patients, caregivers, and clinicians in making decisions about self-management and care.

We aimed to develop a highly interpretable and effective, machine learning (ML)-based risk prediction algorithm to predict in-hospital mortality, intubation, and adverse cardiovascular events in patients hospitalized with coronavirus disease 2019 (COVID-19) in Australia (AUS-COVID Score).

A proof-of-concept study aimed at designing and implementing Visual & Interactive Engagement With Electronic Records (VIEWER), a versatile toolkit for visual analytics of clinical data, and systematically evaluating its effectiveness across various clinical applications while gathering feedback for iterative improvements.